Fig. 1.

Schematic of how each of these molecular groups derived from recently published multiomics studies likely correlate with one another based on NF2 status, copy number alterations, mutational status, transcriptional pathway, and outcome [schematic of relative progression-free survival (PFS) as defined by each respective study]